Showing results 1 to 9 of 9
Title | Author(s) | Issue Date | |
---|---|---|---|
A Phase IIIb open-label, single-arm study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC: An interim analysis. Proceeding/Conference:World Lung Cancer Conference, 2017 | 2017 | ||
Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP Journal:International Journal of Oncology | 2010 | ||
2021 | |||
2017 | |||
2022 | |||
Increased Serum Type I Interferon Level May Predict Outcome in Hepatocellular Carcinoma Patients Treated with Radiotherapy Proceeding/Conference:International Journal of Radiation Oncology, Biology, Physics | 2020 | ||
p53 inactivating mutations in Chinese nasopharyngeal carcinomas Journal:Cancer Letters | 1998 | ||
2018 | |||
2020 |